CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important ...

Scott Drutman Incoming Chief Medical Officer of Enara Bio Boehringer Ingelheim exercises option to license additional Dark ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...

A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

At the recent American Society of Hematology annual meeting, researchers presented preclinical data examining how ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell-known as helper T cells-from stem cells in a ...

Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment.